Some of the contents of this website cannot be promoted in the USA (including its territories and possessions) for regulatory reasons.

Please choose your country/geographic area:

International

USA **including its territories and possessions

Fotona
  • For Ladies
  • For Doctors
  • About Fotona
    • About Fotona
    • Fotona Technology
  • Contact
  • Menu Menu
  • For Ladies
    • Treatments
      • IncontiLase®Stress urinary incontinence treatment
      • IntimaLase®Vaginal tightening treatment
      • RenovaLase®Treatment for genitourinary syndome of menopause / vaginal atrophy
      • ProlapLase®Pelvic organ prolapse treatment
    • Articles
    • FAQ
    • Ask an Expert
    • Find a Doctor
  • For Doctors
    • Treatments
      • IncontiLase®Laser treatment for stress and mixed urinary incontinence
      • IntimaLase®Vaginal tightening treatment
      • RenovaLase®Treatment for genitourinary syndrome of menopause / vaginal atrophy
      • ProlapLase®Laser treatment for pelvic organ prolapse
    • Products
      • TimeWalker® IntimaLaser™
      • FotonaSmooth® SP
      • FotonaSmooth® XS
    • Events
      • Trainings & Workshops
      • Conferences & Exhibitions
      • News
    • Knowledge base
      • Selected Abstracts
      • Scientific Publications
    • FAQ
  • About us
    • Fotona
    • Fotona Technology
  • Contact
    • Talk to Us
    • Find a Distributor
  • Treatments
    • IncontiLase®Stress urinary incontinence treatment
    • IntimaLase®Vaginal tightening treatment
    • RenovaLase®Treatment for genitourinary syndome of menopause / vaginal atrophy
    • ProlapLase®Pelvic organ prolapse treatment
  • Articles
  • FAQ
  • Ask an Expert
  • Find a Doctor
  • Treatments
    • IncontiLase®Laser treatment for stress and mixed urinary incontinence
    • IntimaLase®Vaginal tightening treatment
    • RenovaLase®Treatment for genitourinary syndrome of menopause / vaginal atrophy
    • ProlapLase®Laser treatment for pelvic organ prolapse
  • Products
    • TimeWalker® IntimaLaser™
    • FotonaSmooth® SP
    • FotonaSmooth® XS
  • Events
    • Trainings & Workshops
    • Conferences & Exhibitions
    • News
  • Knowledge Base
    • Selected Abstracts
    • Scientific Publications
  • FAQ
  • Talk to Us
  • Find a Distributor
  • For Ladies
    • Treatments
      • IncontiLase®Stress urinary incontinence treatment
      • IntimaLase®Vaginal tightening treatment
      • RenovaLase®Treatment for genitourinary syndome of menopause / vaginal atrophy
      • ProlapLase®Pelvic organ prolapse treatment
    • Articles
    • FAQ
    • Ask an Expert
    • Find a Doctor
  • For Doctors
    • Treatments
      • IncontiLase®Laser treatment for stress and mixed urinary incontinence
      • IntimaLase®Vaginal tightening treatment
      • RenovaLase®Treatment for genitourinary syndrome of menopause / vaginal atrophy
      • ProlapLase®Laser treatment for pelvic organ prolapse
    • Products
      • TimeWalker® IntimaLaser™
      • FotonaSmooth® SP
      • FotonaSmooth® XS
    • Events
      • Trainings & Workshops
      • Conferences & Exhibitions
      • News
    • Knowledge base
      • Selected Abstracts
      • Scientific Publications
    • FAQ
  • About us
    • Fotona
    • Fotona Technology
  • Contact
    • Talk to Us
    • Find a Distributor

Significant reduction of all symptoms without side effects

RenovaLase®

Treatment for genitourinary syndrome of menopause / vaginal atrophy

Gently restoring vaginal function and comfort in post-menopausal women

  • a non-ablative Er:YAG photo-thermal treatment of the vaginal canal
  • improved vascularization and trophism of the vaginal wall
  • collagen regeneration and improved water content
  • incisionless, minimally invasive
  • no anesthesia needed
  • walk-in/walk-out procedure
  • little-to-no downtime
What is RenovaLase®?

RenovaLase® is a laser treatment for the menopause-associated vaginal atrophy that delivers gentle Fotona SMOOTH® laser pulses to stimulate renewal of the vaginal mucous surface, which can then produce improved levels of lubrication and relieve vaginal dryness and discomfort. RenovaLase® vaginal atrophy treatment produces results that can last more than a year, without the need for constant applications of cream and gels, thus making sexuality in the golden years more enjoyable and effortless. It has shown excellent results in women suffering from vaginal atrophy symptoms such as vaginal dryness, irritation and dyspareunia, including breast cancer survivors.

How does RenovaLase® work?

  • laser-induced, mild and controlled heating of the vaginal tissue
  • stimulation of angiogenesis, fibroblast activity and new collagen formation
  • no thermal or ablative damage
  • the final result is increased epithelial thickness as well as vascularization, along with a reduction of symptoms such as dryness, itching, irritation and dyspareunia

Play video

Unique advantages of RenovaLase® for your patients

For the majority of patients, three sessions of RenovaLase® with a one-month interval were sufficient to achieve noticeable results. No special pre-op preparations or post-op precautions are necessary. Patients can immediately return to their normal everyday activities. Additional advantages of RenovaLase® are that the procedure is incisionless and virtually painless, with no ablation, cutting, bleeding, or sutures. Recovery is extremely quick without need for the use of analgesics or antibiotics.

Excellent results from numerous clinical studies

Effect of RenovaLase® on GSM symptoms in breast cancer survivors.

RenovaLase signifficantly decreased the severity of dyspareunia in breast cancer survivors suffering from GSM, the effect lasting more than 12 months after treatment. Gambacciani, Marco, and Marco Levancini. “Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.” Menopause 24.3 (2017): 316-319

Interested in more scientific content?

More from the Knowledge Base

Scientific Evidence Behind Fotona SMOOTH® Treatments in Gynecology

Compendium of Clinical Studies

Also see:

Scientific & Clinical Research


View LA&HA Lectures

*This content is exclusively for users who have registered their Fotona laser system. To register your system, please click here.

Selected Abstracts

Genitourinary Syndrome of Menopause

RenovaLase® treatment induces significant improvement of genitourinary syndrome of menopause (GSM)

Read

Doctors for Ladies

Prof. Marco Gambacciani, Director of the Menopause Center

Pisa University Hospital

Pisa, Italy

»I have treated hundreds of women, and we have published many papers about the significant and rapid effects of RenovaLase®. In normal postmenopausal women, the effects of VEL (vaginal erbium laser op.ed.) are very rapid... compared with the standard hormonal therapies, but also longer-lasting – up to 12-18 months after the laser application. In our studies, 83% of our patients asked to repeat the treatment: in my mind, this is the best demonstration of the effectiveness of VEL on vaginal atrophy. VEL is the best treatment for breast cancer survivors. With these women, hormonal therapies are not allowed, and these women, often young in their thirties and forties, are really “lone survivors” left alone by practicing physicians, oncologists, and gynecologists. Their sexual life becomes a real nightmare after the iatrogenic menopause. With RenovaLase® the effects are astonishing and their sexual life is not jeopardized by atrophy anymore, without hormones and also without the annoying moisturizers and lubricants.«

More

Less

Doctors Video Testimonials

Marco Gambacciani, MD

Pisa University Hospital

Pisa, Italy

video

Tamas Major, MD, PhD

Debrecen Gynecology Laser Center

Debrecen, Hungary

video

Top Doctors FAQ

Is special preparation of the vaginal canal necessary before performing the RenovaLase® procedure in menopausal women?

Some doctors prescribe the patient a local hormonal gel a few weeks prior to the treatment in severe cases of vaginal atrophy, in order to make the treatment more comfortable. However, many doctors and published studies have reported that there is no special preparation necessary.

Is local anesthesia necessary to apply prior to treatment?

Local anesthesia is not required, as the treatment is not painful (up to 3 on a 1 to 10 VAS scale). However, some physicians use topical anesthetic cream to completely avoid any discomfort, especially for sensitive patients.

Are the patients required to have a gynecological examination prior to taking the treatment?

Yes, a standard gynecological examination, including a pap-smear, should be performed prior to receiving the treatment.

How soon should the patients expect results after having the procedure?

Although an improvement of symptoms is usually noticed already a few days after the procedure, optimal results start to show from one month to six weeks after the initial treatments, as the effects are due to the formation of new collagen in the treated tissue.

Who can perform the treatments?

Generally, treatments are performed by OB/GYN specialists, although in some countries other specialists can also perform the treatment. We recommend that in such cases, the treatments should be done in close collaboration with a patient gynecologist, in order to obtain the required pre-treatment information.

All FAQ For Doctors

Want to know more about RenovaLase®?

Download e-Booklet

  • This field is for validation purposes and should be left unchanged.

See IncontiLase® in action

Check Trainings & Workshops

FotonaSmooth® Lasers

RenovaLase® can be performed using following lasers:

FotonaSmooth® SP

  • Two complementary laser wavelengths in one system: 2940 nm Er:YAG and 1064 nm Nd:YAG
  • Fotona SMOOTH® mode technology for non-invasive treatments
  • Er:YAG VSP technology for cold to warm ablation
  • Non-surgical treatments of lesions of the vagina and uterine neck
  • Nd:YAG for additional clinical and aesthetic applications

More

FotonaSmooth® XS

    • 2940 nm Er:YAG laser
    • Fotona SMOOTH® mode technology for non-invasive treatments
    • VSP technology for cold to warm ablation
    • Non-surgical treatments of lesions of the vagina and uterine neck

More

TimeWalker® IntimaLaser™

  • Two complementary laser wavelengths in one system: 2940 nm Er:YAG and 1064 nm Nd:YAG
  • Fotona SMOOTH® mode technology for non-invasive treatments
  • Er:YAG VSP technology for cold to warm ablation
  • Non-surgical treatments of lesions of the vagina and uterine neck
  • Nd:YAG for additional clinical and aesthetic applications

More

lorem ipsum

  • For Ladies
    • Treatments
      • IncontiLase®
      • IntimaLase®
      • RenovaLase®
      • ProlapLase®
    • Articles
    • FAQ
    • Find a Doctor
    • Ask an Expert
  • For Doctors
    • Treatments
      • IncontiLase®
      • IntimaLase®
      • RenovaLase®
      • ProlapLase®
    • Products
      • TimeWalker® IntimaLaser™
      • FotonaSmooth® SP
      • FotonaSmooth® XS
    • Events
      • Trainings & Workshops
      • Conferences & Exhibitions
      • News
    • Knowledge base
      • Selected Abstracts
      • Scientific Publications
    • FAQ
  • About us
    • About Fotona
    • Fotona Technology
  • Contact
    • Talk to Us
    • Find a Distributor
  • Privacy Policy

Find More Knowledge On:

Join Us on Social Networks

Download Fotona Mobile Application

All information published in this website is of general nature and only has an informative purpose. Under no circumstances can it replace any treatment or therapy prescribed by a physician or other healthcare professional. Any information on medical procedures and treatments in this website are intended for informative purposes only and do not provide the knowledge required for their application.

All Fotona medical lasers are CE marked and cleared for sale in the EU. For countries where specific national approvals or clearances are required (for example by the FDA in the United States), some of the products and/or applications may not have been cleared yet. Similarly, local patents may limit usage for certain technologies and applications. Please check with Fotona, your local Fotona distributor or your national regulatory body to find out whether a specific product or application is available for sale and use in your country.

Fotona 2023 ©

Scroll to top